Skip to content

Investigation of the effects of Peucedanum japonicum root extract on abdominal fat -Randomized, placebo-controlled, double-blind, parallel group study-

Investigation of the effects of Peucedanum japonicum root extract on abdominal fat -Randomized, placebo-controlled, double-blind, parallel group study- - Investigation of the effects of Peucedanum japonicum root extract on abdominal fat

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000057187
Enrollment
30
Registered
2025-04-23
Start date
2025-04-23
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteer

Interventions

Sponsors

Maruzen Pharmaceuticals Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Japanese males and females aged of 20-54 years 2) Participants whose BMI >=23.0 kg/m2 and <30.0 kg/m2 3) Participants who take a lot of fat 4) Participants who can visit on schedule days 5) Participants who recognize the object and contents of the study and submit the written informed consent

Exclusion criteria

Exclusion criteria: 1) Participants who are under treatment or have a history of severe illness in the heart, liver, kidney, digestive organs or other organs 2) Participants who have been diagnosed or taking medication with dyslipidemia, high blood pressure, or diabetes 3) Participants who received medication treatment or surgery due to serious illness or injury within 1 month prior to the start of the study 4) Participants who regularly use health foods and supplements affecting the study 5) Participants who may have difficulties during CT scanning (e.g. claustrophobia, metal in the vicinity of imaging, implanted medical devices in the body) 6) Possible pregnancy, pregnancy and lactation 7) Heavy drinker (over 40g alcohol/day) 8) Smokers 9) Participants who feel bad mood by blood collect 10) Participants who donated 200 mL or more of blood within 1 month prior to the start of the study or participants who plan to do so during the study period 11) Participants who have been diagnosed with chronic constipation 12) Late-night Shift worker 13) Participants who plan business trip or trip on average more than 10 days per month (excluding Obon vacation and New Year's holidays) 14) Participants who have allergy related to the test foods 15) Participants already participating in other clinical trials 16) Participants who are ineligible due to physician's judgment

Design outcomes

Primary

MeasureTime frame
Abdominal visceral fat area

Secondary

MeasureTime frame
Abdominal subcutaneous fat area, abdominal total fat area, body weight, BMI, waist circumference, hip circumference, W/H ratio, total cholesterol, LDL- cholesterol, HDL- cholesterol, triglyceride, glucose, HbA1c

Countries

Japan

Contacts

Public ContactToyotada Ashino

Trans Genic Inc. Clinical Research Department

toyotada.ashino@transgenic.co.jp0123-34-0412

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026